We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Nexium Patent Infringement Suit Settled by AstraZeneca, Teva
Nexium Patent Infringement Suit Settled by AstraZeneca, Teva
January 19, 2010
Teva Pharmaceutical Industries may market a generic version of AstraZeneca’s blockbuster heartburn treatment Nexium in May 2014, now that the companies have settled a patent infringement lawsuit over the drug.